Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Other Accumulated Expenses (2020 - 2022)

Trulieve Cannabis has reported Other Accumulated Expenses over the past 3 years, most recently at $5.8 million for Q4 2022.

  • For Q4 2022, Other Accumulated Expenses fell 12.21% year-over-year to $5.8 million; the TTM value through Dec 2022 reached $5.8 million, down 12.21%, while the annual FY2022 figure was $5.8 million, 12.21% down from the prior year.
  • Other Accumulated Expenses for Q4 2022 was $5.8 million at Trulieve Cannabis, up from $3.4 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $6.6 million in Q4 2021 and troughed at $86000.0 in Q4 2020.
  • A 3-year average of $4.0 million and a median of $4.6 million in 2022 define the central range for Other Accumulated Expenses.
  • Biggest five-year swings in Other Accumulated Expenses: soared 7597.67% in 2021 and later decreased 12.21% in 2022.
  • Year by year, Other Accumulated Expenses stood at $86000.0 in 2020, then soared by 7597.67% to $6.6 million in 2021, then decreased by 12.21% to $5.8 million in 2022.
  • Business Quant data shows Other Accumulated Expenses for TCNNF at $5.8 million in Q4 2022, $3.4 million in Q1 2022, and $6.6 million in Q4 2021.